Navigation Links
U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for Adolescent Patients With Schizophrenia
Date:11/6/2007

ex of all mental health disorders," said Elliott Sigal, M.D., Ph.D., Executive Vice President, Chief Scientific Officer and President, Research and Development, Bristol-Myers Squibb. "We remain committed to providing innovative therapies, such as ABILIFY, to help patients, including adolescents, living with schizophrenia."

Clinical Trial Design and Findings

The findings are from a six-week, double-blind, randomized, placebo- controlled, multi-center study that evaluated the efficacy and safety of ABILIFY in pediatric patients, 13-17 years old, with a primary diagnosis of schizophrenia.(1) The study, sponsored by Otsuka Pharmaceutical Co., Ltd. and its U.S. subsidiary, Otsuka Pharmaceutical Development & Commercialization, Inc. (Princeton, N.J.), was conducted at 101 centers in 13 countries and enrolled 302 ethnically diverse pediatric patients. All patients were experiencing an acute episode of schizophrenia and required hospitalization at the time of enrollment.(1) After a minimum three-day wash-out period without any antipsychotic treatment, pediatric patients were randomly assigned to receive one of two fixed doses of ABILIFY [10 mg/day (n=100) or 30 mg/day (n=102)] or placebo (n=100).(1) ABILIFY was started at 2 mg/day and titrated to the target dose.(1)

The primary efficacy endpoint was the mean change from baseline to endpoint (Week 6) in a standard measure called the PANSS Total Score,(1) which can range from 30 (no symptoms) to 210 points (most severe symptoms).(2) Safety evaluations included incidence of adverse events, discontinuation rate due to adverse events and laboratory measures.(1)

Approximately 85 percent of patients completed the six-week study (84 percent of ABILIFY 10 mg, 82 percent of ABILIFY 30 mg and 90 percent of placebo-treated patients).(1) Both doses of ABILIFY demonstrated significant improvement when compared to placebo in mean change from baseline to endpoint (Week 6) in PANSS Total Score.(1)

In this study
'/>"/>

SOURCE Otsuka Pharmaceutical Co., Ltd.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
2. Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees
3. Wells Fargo Offers Online Benefit Administration for Business and Individual Healthcare Consumers
4. Administration Anesthetized to Ailments of Nations Children
5. Supratek Pharma Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for SP1049C for the treatment of metastatic adenocarcinoma of the upper gastrointestinal tract
6. Siemens Medical Solutions Receives CCHIT Certification for Soarian Clinicals With Siemens Pharmacy and Med Administration Check
7. FDA Approves First Anti-Psychotic for Kids
8. FDA Approves New Roche West Nile Virus Blood Screening Test
9. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
10. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
11. FDA Approves SOMA(R) (carisoprodol) 250 mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 25, 2014 Triton Algae Innovations, ... announced Dr. Xun Wang has joined the ... Development. , Triton has developed a patented synthetic biology ... According to Dr. Wang, the platform uses algae to ... He says, “Algae are unique because they can produce ...
(Date:10/25/2014)... October 26, 2014 BioSkinLaser.Com, the leading ... most advanced and improved laser treatments for its customers. ... treatments like the lip enhancement treatment . It ... specific focus areas of each customer. , BioSkinLaser.Com has ... reduction NYC . The company cited that it created ...
(Date:10/25/2014)... New York, New York (PRWEB) October 25, 2014 ... lawsuits ( http://www.thexareltolawsuit.com/ ) will be addressed in December, ... convenes its next hearing session. According to a Hearing ... Oral Arguments on the matter will be heard on ... Session will begin at 9:30 a.m. (In Re: Xarelto ...
(Date:10/25/2014)... October 25, 2014 The global HCIT ... of 7.6%, to reach $50.4 billion by 2018 from ... systems industry, and pharmaceutical industry are driving the HCIT ... to enhance their focus on core business, reduce operational ... trained staff (further reducing hiring and training costs), share ...
(Date:10/25/2014)... Arriving home safe and sound is one of the best ... that costumes and goody bags have reflective strips that improve ... doctor at Meadowlands Hospital Medical Center in Secaucus, N.J. ... be flame-resistant, Davis said. He offers these others tips: ... on a small area of skin first to ensure it ...
Breaking Medicine News(10 mins):Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 2Health News:Triton Algae Innovations Ltd. Names Dr. Xun Wang as President 3Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 2Health News:BioSkinLaser.Com Now Offers Advanced Medical Aesthetics Procedures 3Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 2Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 3Health News:Global HCIT Outsourcing Market to Grow at 7.6% CAGR to 2018 Says a Premium Research Report Available at ReportsnReports.com 4Health News:Tips for Safe Trick-or-Treating 2
... New Orleans, LA, May 16 Two new ... the American Society of Hypertension (ASH) Twenty-Third Annual ... Orleans show that the milk-derived dietary supplement AmealPeptide ... studies, called AHEAD (Achieve Hypertension Efficacy with AmealPeptide ...
... An AIDS Vaccine is Possible and,Still Urgently Needed, ... of HIV, the world has made considerable advances in ... about HIV,perhaps more than any other pathogen, and have ... diseases combined. But this progress is not,enough. While it ...
... Less than a week after,committing medical relief efforts ... Project HOPE, an international health education and,humanitarian assistance ... to meet the urgent medical needs for the ... which has claimed over,20,000 lives., "I am ...
... based on abstracts or poster presentations at the annual ... to be held in Chicago, Illinois, May 30 ... Biomarker for Early Detection of Malignant Pleural Mesothelioma ... detection and prognostic marker,in malignant pleural mesothelioma, NYU Cancer ...
... are playing a major role in responding to ... ages who experience psychiatric and substance use,conditions each ... the,National Association of Psychiatric Health Systems (NAPHS) released ... two distinct views of behavioral,healthcare delivery. One chapter ...
... Senich, B.S.N., M.B.A.,M.P.H., Roche vice president, Sales and ... Jersey (EWNJ) at its "Salute to the Policy ... 15, 2008 at the Hyatt,Regency New Brunswick, recognized ... senior executives or members of boards of directors ...
Cached Medicine News:Health News:Calpis' AmealPeptide lowers blood pressure in 2 placebo-controlled trials 2Health News:World AIDS Vaccine Day 2008 2Health News:World AIDS Vaccine Day 2008 3Health News:World AIDS Vaccine Day 2008 4Health News:Project HOPE to Send Humanitarian Assistance to China as Humanitarian Assistance to Myanmar Continues 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 3Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 4Health News:New NAPHS Annual Survey Tracks Behavioral Treatment Trends 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 2Health News:Roche Vice President Senich Honored at EWNJ 'Salute to Policy Makers' 3
(Date:10/25/2014)... to a survey by KLAS, an independent research firm, ... the number one ranking in the medical and/or radiology ... report. The survey of 247 customers of various vendors ... take a commanding lead over their competitors." MOSAIQ scored ... they would buy again and 96 percent confirmed that ...
(Date:10/25/2014)... Research and Markets  has announced the ... Opportunities - Global Forecast to 2019" report to ... global dental equipment market is categorized on the basis ... market is expected to register the highest growth rate ... (2014 to 2019). This high growth is attributed to ...
(Date:10/25/2014)... 2014 Advanced Photonix ® (NYSE MKT: API) ... financial results on Monday, November 10, 2014. A press release ... of the market and the Company will host a live ... EDT on the same day. Participating in the ... Rob Risser (COO and Director), and Jeff ...
Breaking Medicine Technology:Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 2Elekta's MOSAIQ oncology information system ranks number one in KLAS Oncology 2014 report 3Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 2Dental Equipment Market Current Trends, Opportunities - Global Forecast to 2019 3Advanced Photonix to Webcast Fiscal 2015 Second Quarter Earnings 2
... 26, 2011 Hamilton Company has been awarded a ... announced today. Hamilton Company, the Reno, NV-based global leader in ... investment in the manufacturing facility of its Swiss subsidiary Hamilton ... Named after Swiss national hero Wilhelm Tell, the Awards are ...
... The World Intellectual Property Organization (WIPO), in an ... Ventures for Global Health (BVGH), launched today ... and private sector organizations share valuable intellectual property ... community to promote development of new drugs, vaccines, ...
Cached Medicine Technology:Hamilton Company Wins Switzerland's 2010 Tell Award for Manufacturing Investment in Grisons, Greater Zurich Area 2Hamilton Company Wins Switzerland's 2010 Tell Award for Manufacturing Investment in Grisons, Greater Zurich Area 3Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 2Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 3Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 4Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 5Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 6Leading Pharmaceutical Companies & Research Institutions Offer IP and Expertise for Use in Treating Neglected Tropical Diseases as Part of WIPO Re:Search 7
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: